Arnon Rosenthal
Förmögenhet: 14 M $ per 2026-05-31
Förmögenhet: 14 M $ per 2026-05-31
Arnon Rosenthal was the founder of Annexon, Inc. (founded in 2011, titled: Chairman from 2014 to 2017), Rinat Neuroscience Corp.
(founded in 2001, titled: President, Director & Chief Scientific Officer from 2001 to 2006), and Alector, Inc. (founded in 2013, titled: Chief Executive Officer & Director since 2019).
Former job at Genentech, Inc. as Scientist from 1985 to 2001.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ALECTOR, INC. 5,67 % | 2026-06-02 | 6 297 581 ( 5,67 % ) | 14 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ALECTOR, INC. | Grundare | 2013-05-01 |
| Företag | Position | Slut |
|---|---|---|
| ANNEXON, INC. | Verkställande Direktör | 2014-12-01 |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Grundare | 2006-08-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2001-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån